Predictors of survival in HIV-infected tuberculosis patients

AIDS

Volumn 10, Issue 3, 1996, Pages 269-272

  Shafer, Robert W ^a   Bloch, Alan B ^b   Larkin, Christina ^c   Vasudavan, Viswanath ^d   Seligman, Stephen ^d   Dehovitz, Jack D ^d   DiFerdinando, George ^e   Stoneburner, Rand ^f   Cauthen, George ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Bureau of STD Control   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^f NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

CD4+ T lymphocytes; HIV; Survival; Tuberculosis; Tuberculosis treatment

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; DEATH; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; T LYMPHOCYTE; THRUSH; TUBERCULOSIS;

EID: 0029913713     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199603000-00005     Document Type: Article

References (18)

1. Narain JP, Raviglione MC, Kochi A: HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992, 73:311-321.
2. Katz P, Goldslein RA, Fauci AS: Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes. J Infect Dis 1979, 140:12-21.
3. Shiratsuchi H, Tsuyugiuhi I: Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin. Clin Exp Immunol 1984, 57:271-278.
4. Onwubalili JK, Edwards AJ, Palmer L: T4 lymphopenia in human tuberculosis. Tuberde 1987, 68:195-200.
5. Shafer KW, Chirgwin KD, Glatt AE, Dahdouh MA, Landesman SH, Suster B: HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991, 5:399-405.
6. SAS/STAT Software: The PHREG Procedure. Cary, NC: SAS Institute, Inc.: 1991.
7. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC: Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991, 324:289-294.
8. Stoneburner R, Laroche E, Prevots R, et al.: Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City: implications for the expansion of the AIDS case definition. Arch Intern Med 1992, 152:2033-2037.
9. Whalen C, Morsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J: Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995, 151:129-135.
10. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987, 36(suppl 1):3-9.
11. Sharer RW, Kim DS, Weiss JP, Quale JD: Extrapulmonary tuberculosis in patients with HIV infection. Medicine 1991, 70:384-397.
12. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF: Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993, 148:1292-1297.
13. Pastores SM, Nadich DP, Aranda CP, McGuinnes G, Rom WN: Intrathoracic adenopathy associated with pulmonary tuberculosis in patients with human immunodeficiency virus infection. Chest 1995, 103:1455-1457.
14. Pozniak AL, Mahari M, Chidede L, et al.: CD4 count and predictors of mortality in dually infected HIV/TB cohort in Africa. IX International Conference on AIDS/IV STD World Congress. Berlin, June 1995 [abstract PO-B07-1141].
15. Scwander S, Rusch-Gerdes S, Mateega A, et al.: A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. Tubercle Lung Dis 1995, 76:210-218.
16. Jones BE, Otaya M, Antoniskis D, et al.: A prospective evaluation of antituberculosis therapy in patients with HIV infection. Am J Respir Crit Care Med 1994, 150:1499-1502.
17. Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE: Effectiveness of supervised intermittent therapy for tuberculosis in HIV-infected patients. AIDS 1994, 8:1103-1108.
18. Perriens JH, St Louis ME, Mukadi YB, et al.: Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995, 332:779-784.